Raghutaz 4000mg/500mg Injection
Marketer
Godrams Lifeline
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Raghutaz 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity and must be meticulously followed. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening symptoms necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, liver, or kidney impairments; dosage adjustments or alternative therapies may be necessary. While generally considered safe under medical guidance, its use during pregnancy and breastfeeding requires physician oversight.
Uses of Raghutaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Raghutaz 4000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Raghutaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Raghutaz 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Raghutaz 4000mg/500mg Injection works:
Raghutaz Injection, containing 4000mg of piperacillin and 500mg of tazobactam, employs a dual-drug approach to combat bacterial infections. Piperacillin, a potent antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Raghutaz 4000mg/500mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Raghutaz, at a dosage of 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal to no negative impacts on fetal development; nonetheless, research involving human subjects is currently insufficient.
Breast feedingSAFE IF PRESCRIBED
Administration of Raghutaz 4000mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Raghutaz 4000mg/500mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Raghutaz 4000mg/500mg Injection requires careful consideration in individuals suffering from renal impairment. Dosage modification of Raghutaz 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Raghutaz 4000mg/500mg Injection in patients with hepatic impairment is likely safe. Preliminary findings indicate dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Raghutaz 4000mg/500mg Injection :
Omitting a scheduled dose of Raghutaz 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Raghutaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently